Acipimox in Mitochondrial Myopathy (AIMM): study protocol for a randomised, double-blinded, placebo-controlled, adaptive design trial of the efficacy of acipimox in adult patients with mitochondrial myopathy.
AIMM Trial Group:; Abouhajar A, Alcock L, Bigirumurame T, Bradley P, Brown L, Campbell I, Del Din S, Faitg J, Falkous G, Gorman GS, Lakey R, McFarland R, Newman J, Rochester L, Ryan V, Smith H, Steel A, Stefanetti RJ, Su H, Taylor RW, Thomas NJP, Tuppen H, Vincent AE, Warren C, Watson G.
AIMM Trial Group:, et al. Among authors: bigirumurame t.
Trials. 2022 Sep 20;23(1):789. doi: 10.1186/s13063-022-06544-x.
Trials. 2022.
PMID: 36127727
Free PMC article.